Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Emergence and spread of plasmid-borne tet(B)::ISCR2 in minocycline-resistant Acinetobacter baumannii isolates.

Vilacoba E, Almuzara M, Gulone L, Traglia GM, Figueroa SA, Sly G, Fernández A, Centrón D, Ramírez MS.

Antimicrob Agents Chemother. 2013 Jan;57(1):651-4. doi: 10.1128/AAC.01751-12. Epub 2012 Nov 12.

PMID:
23147737
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals.

Huys G, Cnockaert M, Vaneechoutte M, Woodford N, Nemec A, Dijkshoorn L, Swings J.

Res Microbiol. 2005 Apr;156(3):348-55. Epub 2004 Dec 15.

PMID:
15808938
[PubMed - indexed for MEDLINE]
3.

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.

Arroyo LA, Mateos I, González V, Aznar J.

Antimicrob Agents Chemother. 2009 Mar;53(3):1295-6. doi: 10.1128/AAC.01097-08. Epub 2008 Dec 15. No abstract available.

PMID:
19075049
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline.

Hua X, Zhou H, Jiang Y, Feng Y, Chen Q, Ruan Z, Yu Y.

J Bacteriol. 2012 Dec;194(24):6979-80. doi: 10.1128/JB.01887-12.

PMID:
23209232
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.

Ricciardi R, Ricciardi AM, Danzi G.

Infez Med. 2009 Dec;17(4):236-9.

PMID:
20046104
[PubMed - indexed for MEDLINE]
Free Article
6.

[Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates].

Martí S, Fernández-Cuenca F, Pascual A, Ribera A, Rodríguez-Baño J, Bou G, Miguel Cisneros J, Pachón J, Martínez-Martínez L, Vila J; Grupo de Estudio de Infección Hospitalaria (GEIH).

Enferm Infecc Microbiol Clin. 2006 Feb;24(2):77-80. Spanish.

PMID:
16545313
[PubMed - indexed for MEDLINE]
7.

Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.

Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L.

J Antimicrob Chemother. 2008 Sep;62(3):484-9. doi: 10.1093/jac/dkn205. Epub 2008 May 13.

PMID:
18477708
[PubMed - indexed for MEDLINE]
Free Article
8.

Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.

Curcio D, Fernández F.

J Antimicrob Chemother. 2007 Aug;60(2):449-50. Epub 2007 Jun 7. No abstract available.

PMID:
17561503
[PubMed - indexed for MEDLINE]
Free Article
9.

Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City.

Barbolla RE, Centrón D, Di Martino A, Maimone S, Salgueira C, Famiglietti A, Vay C, Catalano M.

Diagn Microbiol Infect Dis. 2003 Apr;45(4):261-4.

PMID:
12729996
[PubMed - indexed for MEDLINE]
10.

Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.

Chang KC, Lin MF, Lin NT, Wu WJ, Kuo HY, Lin TY, Yang TL, Chen YC, Liou ML.

J Microbiol Immunol Infect. 2012 Feb;45(1):37-42. doi: 10.1016/j.jmii.2011.09.019. Epub 2011 Dec 8.

PMID:
22154678
[PubMed - indexed for MEDLINE]
11.

Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne new delhi metallo-β-lactamase in Honduras.

Waterman PE, McGann P, Snesrud E, Clifford RJ, Kwak YI, Munoz-Urbizo IP, Tabora-Castellanos J, Milillo M, Preston L, Aviles R, Sutter DE, Lesho EP.

Antimicrob Agents Chemother. 2013 Sep;57(9):4584-6. doi: 10.1128/AAC.00275-13. Epub 2013 Jul 1.

PMID:
23817381
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains.

Guardabassi L, Dijkshoorn L, Collard JM, Olsen JE, Dalsgaard A.

J Med Microbiol. 2000 Oct;49(10):929-36.

PMID:
11023190
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.

Seifert H, Stefanik D, Wisplinghoff H.

J Antimicrob Chemother. 2006 Nov;58(5):1099-100. Epub 2006 Sep 14. No abstract available.

PMID:
16980293
[PubMed - indexed for MEDLINE]
Free Article
14.

Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii.

Ribera A, Ruiz J, Vila J.

Antimicrob Agents Chemother. 2003 Jul;47(7):2310-2.

PMID:
12821485
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.

Park YK, Jung SI, Park KH, Kim DH, Choi JY, Kim SH, Ko KS.

J Med Microbiol. 2012 Jan;61(Pt 1):71-9. doi: 10.1099/jmm.0.033852-0. Epub 2011 Aug 18.

PMID:
21852525
[PubMed - indexed for MEDLINE]
16.

Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital.

Akers KS, Mende K, Yun HC, Hospenthal DR, Beckius ML, Yu X, Murray CK.

Antimicrob Agents Chemother. 2009 Jun;53(6):2693-5. doi: 10.1128/AAC.01405-08. Epub 2009 Mar 23.

PMID:
19307365
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.

Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S188-91. doi: 10.1016/S0924-8579(08)70026-8.

PMID:
19013353
[PubMed - indexed for MEDLINE]
18.

In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.

Pei G, Mao Y, Sun Y.

Microb Drug Resist. 2012 Dec;18(6):574-7. doi: 10.1089/mdr.2012.0076. Epub 2012 Aug 28.

PMID:
22928863
[PubMed - indexed for MEDLINE]
19.

A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.

Zarrilli R, Vitale D, Di Popolo A, Bagattini M, Daoud Z, Khan AU, Afif C, Triassi M.

Antimicrob Agents Chemother. 2008 Nov;52(11):4115-20. doi: 10.1128/AAC.00366-08. Epub 2008 Aug 25.

PMID:
18725447
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.

Cui JC, Liu YN, Chen LA.

J Antibiot (Tokyo). 2010 Jan;63(1):29-31. doi: 10.1038/ja.2009.111. Epub 2009 Nov 13. No abstract available.

PMID:
19911030
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk